Ratings by Raymond James (Dane Leone)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/19/2021 Cytokinetics CYTK Maintain Outperform
(N/A)
 
 
  Details
6/29/2021 Tarsus Pharmaceuticals TARS Maintain Strong Buy
(N/A)
 
 
  Details
3/26/2021 Cytokinetics CYTK Maintain Outperform
(N/A)
 
 
  Details
2/24/2021 Xencor, Inc. XNCR Upgrade Outperform
(Market Perform)
48.35
(30.78)
-36.34% Details
2/19/2021 Galapagos NV GLPG Upgrade Outperform
(Market Perform)
83.80
(60.54)
-27.76% Details
2/16/2021 G1 Therapeutics GTHX Maintain Outperform
(N/A)
 
 
  Details
2/11/2021 Regenxbio Inc. RGNX Maintain Strong Buy
(N/A)
 
 
  Details
2/2/2021 Sage Therapeutics SAGE New Coverage Market Perform
(N/A)
80.65
(43.73)
-45.78% Details
1/6/2021 Regenxbio Inc. RGNX Upgrade Strong Buy
(Outperform)
44.91
(32.32)
-28.03% Details
11/30/2020 Sage Therapeutics SAGE Downgrade Market Perform
(Outperform)
75.57
(43.73)
-42.13% Details
11/17/2020 G1 Therapeutics GTHX Downgrade Outperform
(Strong Buy)
13.19
(17.31)
31.24% Details
11/13/2020 Ocular Therapeutix OCUL Maintain Strong Buy
(N/A)
 
 
  Details
11/12/2020 Adverum Biotechnologies ADVM Upgrade Market Perform
(Underperform)
13.37
(2.27)
-83.02% Details
11/10/2020 Tarsus Pharmaceuticals TARS New Coverage Strong Buy
(N/A)
23.19
(22.57)
-2.67% Details
10/26/2020 Amgen AMGN Upgrade Outperform
(Market Perform)
227.98
(241.54)
5.95% Details
10/16/2020 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
10/16/2020 Simulations Plus SLP New Coverage Outperform
(N/A)
71.90
(47.19)
-34.37% Details
10/8/2020 Cytokinetics CYTK Downgrade Outperform
(Strong Buy)
27.66
(29.68)
7.3% Details
10/8/2020 Amgen AMGN Downgrade Market Perform
(Outperform)
257.67
(241.54)
-6.26% Details
9/22/2020 Bristol-Myers Squibb Co. BMY Maintain Outperform
(N/A)
 
 
  Details
9/21/2020 Amgen AMGN Maintain Outperform
(N/A)
 
 
  Details
8/10/2020 Sage Therapeutics SAGE Upgrade Outperform
(Market Perform)
50.70
(75.57)
49.05% Details
7/28/2020 Bristol-Myers Squibb Co. BMY New Coverage Outperform
(N/A)
57.85
(67.87)
17.32% Details
7/14/2020 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
7/10/2020 Cytokinetics CYTK New Coverage Strong Buy
(N/A)
26.92
(27.66)
2.75% Details
6/26/2020 Adverum Biotechnologies ADVM Downgrade Underperform
(Market Perform)
23.32
(13.37)
-42.67% Details
6/11/2020 Magenta Therapeutics MGTA Maintain Outperform
(N/A)
 
 
  Details
6/10/2020 Ayala Pharmaceuticals AYLA New Coverage Outperform
(N/A)
15.16
(12.50)
-17.55% Details
6/1/2020 Allogene ALLO Downgrade Market Perform
(Outperform)
46.54
(21.95)
-52.84% Details
4/28/2020 Blueprint Medicines BPMC Maintain Strong Buy
(N/A)
 
 
  Details
3/30/2020 Amgen AMGN Upgrade Outperform
(Market Perform)
198.49
(257.67)
29.82% Details
3/3/2020 Ocular Therapeutix OCUL Upgrade Strong Buy
(Outperform)
4.69
(11.01)
134.75% Details
2/20/2020 bluebird bio BLUE Downgrade Market Perform
(Strong Buy)
88.22
(25.43)
-71.17% Details
2/19/2020 bluebird bio BLUE Downgrade Market Perform
(Strong Buy)
88.22
(25.43)
-71.17% Details
2/10/2020 Ocular Therapeutix OCUL Maintain Outperform
(N/A)
 
 
  Details
1/6/2020 BridgeBio Pharma BBIO Maintain Outperform
(N/A)
 
 
  Details
12/24/2019 Regeneron Pharma REGN New Coverage Market Perform
(N/A)
375.62
(574.61)
52.98% Details
12/24/2019 Amgen AMGN New Coverage Market Perform
(N/A)
243.06
(198.49)
-18.34% Details
11/5/2019 Blueprint Medicines BPMC Upgrade Strong Buy
(Outperform)
67.12
(87.87)
30.91% Details
9/11/2019 Blueprint Medicines BPMC Upgrade Outperform
(Market Perform)
72.90
(67.12)
-7.93% Details
8/15/2019 Blueprint Medicines BPMC New Coverage Market Perform
(N/A)
85.76
(72.90)
-15% Details
8/7/2019 Xencor, Inc. XNCR Downgrade Market Perform
(Outperform)
46.27
(48.35)
4.5% Details
7/26/2019 BridgeBio Pharma BBIO New Coverage Outperform
(N/A)
28.12
(53.45)
90.08% Details
7/15/2019 Galapagos NV GLPG Downgrade Market Perform
(Strong Buy)
145.75
(83.80)
-42.5% Details
6/14/2019 BioTime, Inc. BTX New Coverage Market Perform
(N/A)
1.00
(11.49)
1049% Details
6/14/2019 Regenxbio Inc. RGNX New Coverage Outperform
(N/A)
46.85
(32.32)
-31.01% Details
6/14/2019 Adverum Biotechnologies ADVM New Coverage Market Perform
(N/A)
11.06
(23.32)
110.85% Details
5/21/2019 Ocular Therapeutix OCUL Downgrade Outperform
(Strong Buy)
3.37
(4.69)
39.17% Details
3/15/2019 Xencor, Inc. XNCR New Coverage Outperform
(N/A)
29.28
(46.27)
58.03% Details
3/15/2019 Magenta Therapeutics MGTA New Coverage Outperform
(N/A)
14.27
(7.12)
-50.11% Details
3/15/2019 Gritstone Oncology GRTS New Coverage Outperform
(N/A)
10.74
(6.68)
-37.8% Details
3/14/2019 Allogene ALLO New Coverage Outperform
(N/A)
26.89
(46.54)
73.08% Details
3/8/2019 Ocular Therapeutix OCUL Maintain Strong Buy
(N/A)
 
 
  Details
1/7/2019 Loxo Oncology LOXO Downgrade Market Perform
(Strong Buy)
139.87
(234.80)
67.87% Details
12/3/2018 Ocular Therapeutix OCUL Maintain Strong Buy
(N/A)
 
 
  Details
11/15/2018 Ocular Therapeutix OCUL New Coverage Strong Buy
(N/A)
5.29
(3.37)
-36.29% Details
11/15/2018 Loxo Oncology LOXO New Coverage Strong Buy
(N/A)
159.08
(139.87)
-12.08% Details
11/15/2018 Galapagos NV GLPG New Coverage Strong Buy
(N/A)
102.79
(145.75)
41.79% Details